Learn More
Medchemexpress LLC IACS-13909 | 2160546-07-4 | 100.0% | 377.27 | 1 ML

Supplier: Medchemexpress LLC HY13709210MM/1ML
IACS-13909 is a selective, potent, and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. It demonstrates greater selectivity for SHP2 compared to other phosphatases, including SHP1. This inhibitor exhibits antitumor activities and inhibits MAPK pathway signaling in receptor tyrosine kinase (RTK)-dependent cancers.
- Selective, potent, and orally active SHP2 allosteric inhibitor
- IC50 of 15.7 nM and Kd of 32 nM for SHP2
- Greater selectivity for SHP2 compared to other phosphatases
- Exhibits antitumor activities
- Inhibits MAPK pathway signaling in RTK-dependent cancers
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.